Volume 2, Issue 2 (7-2020)                   Plant Biotechnol Persa 2020, 2(2): 21-23 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Farhad N, Shahsavari S. Probiotics and their effects in reduction hyperlipidemia. Plant Biotechnol Persa. 2020; 2 (2) :21-23
URL: http://pbp.medilam.ac.ir/article-1-53-en.html
Department of Pathology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
Abstract:   (319 Views)
Hyperlipidemia is a chronic condition but in many cases it may be reversed by a healthy diet and regular exercise. It is also associated to metabolic syndrome, diabetes, and obesity. Hyperlipidemia is known as one of the risk factors for coronary vessels disease, peripheral artery disease, and cardiac arrest. Drug-therapy is a usual method for treating hyperlipidemia. Consumption of probiotics may improve this problem and reduce the course of disease as well as its signs. The purpose of this review is to assess clinical evidences associating to role and effects of probiotics on the hl. Probiotics have greater influence on persons who suffer from high cholesterol. In the intestine, probiotics can bind to cholesterol and prevent its ingestion. Furthermore, they help in production of some biliary acids which play role in lipid and cholesterol metabolism. Some probiotics can produce short chain fatty acids that prevent formation of cholesterol in the liver. Probiotics are effective factors in reduction of hl.
Full-Text [PDF 158 kb]   (261 Downloads)    
Type of Study: Research | Subject: Special
Received: 2020/04/7 | Accepted: 2020/08/25 | Published: 2020/11/25

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.